Page 372 - Read Online
P. 372

Xiong et al.                                                                                                                                                                                          ECM in tumor progression

           deposited by cancer cells promotes cell proliferation,   Conflicts of interest
           migration, invasion, metastasis, multidrug resistance,   There are no conflicts of interest.
           and  tumor-associated  angiogenesis. [15,56,57]  TNC  that
           is derived from disseminated  tumor cells promotes   Patient consent
           lung  metastasis by enhancing  NOTCH and  WNT      No patient involved.
           signaling pathways [Figure 1]. [8,16,18]  In addition, cancer
           cell-derived  ECM  proteins  (fibronectin,  collagen,  and   Ethics approval
           laminin) protect  cancer cells from chemotherapy-  This article does not contain any studies with human
           induced  apoptosis  via activation  of the PI3k/AKT   participants or animals.
           pathway [Figure 1]. [72,73]                        REFERENCES

           Cancer cell-derived ECM proteins mediate the cancer   1.   Bissell MJ, Hines WC. Why don’t we get more cancer? A proposed
           cell-stromal cell crosstalk. Hyaluronan production by   role of the microenvironment in restraining cancer progression. Nat
           stroma fibroblasts is stimulated by factors secreted by   Med 2011;17:320-9.
           cancer cells. [74,75]  Metastatic niche molecule POSTN is   2.   Zhu J, Xiong G, Trinkle C, Xu R. Integrated extracellular matrix
           secreted  by  stoma  fibroblasts  of  breast  tumor  under   signaling in mammary gland development and breast cancer
           stimulation from  the  tumor  cells that  are produced   3.   progression. Histol Histopathol 2014;29:1083-92.
                                                                 Spencer VA, Xu R, Bissell MJ. Extracellular matrix, nuclear and
           TGF-β3  [Figure 1]. [8,16-18]  Cancer cells also remotely   chromatin structure, and gene expression in normal tissues and malignant
           recruit stromal cells  to create a premetastatic  niche   tumors: a work in progress. Adv Cancer Res 2007; 97:275-94.
           before metastasis. Cancer cells-derived TNC initiates   4.   Xu R, Boudreau A, Bissell MJ. Tissue architecture and function:
           cancer cell metastasis, and then it stimulates stroma   dynamic reciprocity via extra- and intra-cellular matrices. Cancer
           cell-derived TNC synthesis. Ablation of TNC expression   5.   Metastasis Re 2009;28:167-76.
                                                                 Xu R, Nelson CM, Muschler JL, Veiseh M, Vonderhaar BK, Bissell
           in cancer cells at an early time in the metastatic process   MJ. Sustained activation of STAT5 is essential for chromatin
           inhibits the outgrowth of lung metastases. Interestingly,   remodeling and maintenance of mammary-specific function. J Cell
           inhibition  TNC expression  in cancer cells at a late   Biol 2009;184:57-66.
           stage of metastasis does not affect micrometastases   6.   Cox TR, Erler JT. Remodeling and homeostasis of the extracellular
           expanding  to macrometastases, because  metastatic    matrix: implications for fibrotic diseases and cancer. Dis Model Mech
           cancer  cells  have already  induced  TNC expression   7.   2011;4:165-78.
                                                                 Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche
           in stromal cells to promote tumor growth. [8,16,18]  These   in cancer progression. J Cell Biol 2012;196:395-406.
           results indicate that cancer cell-derived ECM molecules   8.   Oskarsson T, Massague J. Extracellular matrix players in metastatic
           are critical regulators of the initiation of metastasis   niches. EMBO J 2012;31:254-6.
           outgrowth through  activating the stromal cells in the   9.   Pickup MW, Mouw JK, Weaver VM. The extracellular matrix
           secondary organs [Figure 1].                          modulates the hallmarks of cancer. EMBO Rep 2014;15:1243-53.
                                                              10.  Canty EG, Kadler KE. Procollagen trafficking, processing and
                                                                 fibrillogenesis. J Cell Sci 2005;118:1341-53.
           CONCLUSION                                         11.  Lochter A, Bissell MJ. Involvement of extracellular matrix
                                                                 constituents in breast cancer. Semin Cancer Biol 1995;6:165-73.
           In  summary,  tumor cells play critical roles in ECM   12.  Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG,
           deposition and remodeling during cancer development   Keely PJ. Collagen reorganization at the tumor-stromal interface
                                                                 facilitates local invasion. BMC Med 2006 26;4:38.
           and progression. Accumulated evidence demonstrates   13.  Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden
           that ECM molecules  deposited by cancer cells         CT, White JG, Keely PJ. Collagen density promotes mammary tumor
           promote  cancer progression by enhancing  cell        initiation and progression. BMC Med 2008;6:11.
           survival and proliferation. However, it largely remains   14.  Aguilera KY, Rivera LB, Hur H, Carbon JG, Toombs JE, Goldstein
           to be determined  how  cancer  cell-derived  ECM is   CD, Dellinger MT, Castrillon DH, Brekken RA. Collagen
           regulated  and how those ECM proteins  function in    signaling enhances tumor progression after anti-VEGF therapy in
                                                                 a murine model of pancreatic ductal adenocarcinoma. Cancer Res
           tumor microenvironment remodeling. Answering those    2014;74:1032-44.
           questions  is critical for developing  potential  cancer   15.  Götte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a
           treatment  strategies by  targeting the  cancer cell-  breast carcinoma perspective. Cancer Res 2006;66:10233-7.
           derived ECM and ECM-related enzymes.               16.  Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N,
                                                                 Kudo A. Incorporation of tenascin-C into the extracellular matrix by
           Financial support and sponsorship                     periostin underlies an extracellular meshwork architecture. J Biol
                                                                 Chem 2010;285:2028-39.
           This study was supported by start-up funding from   17.  Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA,
           Markey Cancer Center and funding support from United   Delaloye JF, Huelsken J. Interactions between cancer stem cells and
           States Department of Defense (W81XWH-15-1-0052        their niche govern metastatic colonization. Nature 2012;481:85-9.
           to R.X.).                                          18.  Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF,
            362                                                            Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ September 18, 2016
   367   368   369   370   371   372   373   374   375   376   377